Regulatory Blog

Obtaining marketing authorisation for medicinal products in Ireland requires careful planning and early engagement with the Health Products Regulatory Authority (HPRA). To support efficient assessment and resource management, the HPRA has established guidance for companies seeking to submit new national marketing authorisation applications and for applicants requesting Ireland to act as the Reference Member State (RMS) in a Decentralised Procedure (DCP). The guidance document